Objective: This multi-center retrospective study aimed to clarify the characteristics, diagnostic accuracy, treatment outcomes, and prognostic factors of uterine serous carcinoma (USC) in Japanese women. Methods: The medical records of 193 patients who were treated between 2006 and 2008 at 24 participating institutions in the Japanese Clinical Oncology Group were examined, and pathological slides of 188 patients were re-checked through central pathology review (CPR), hematoxylin-eosin staining, and immunohistochemistry. Results: USC was confirmed in 144 of the 188 (76.6%) patients using CPR, and only 50% were correctly diagnosed preoperatively. Forty-three patients were diagnosed with non-serous carcinoma, whereas one patient had metastasis from another organ. The average age was 65.7 years, and 19% of patients had a history of other cancers. The incidence of stage III–IV disease was 52.8%, and lymph node metastasis was found in 28.5% of patients. Extrauterine spread and distant metastasis occurred in 39% and 14% of patients, respectively. The 2-year overall survival and progression-free survival (PFS) rates were 56% and 42%, respectively. The PFS of patients with stage I and II who underwent complete staging surgery was 92.3%, and that of those without lymph node dissection or omentectomy was 33.3%. Patients with USC had a significantly worse prognosis than 43 patients with non-serous carcinoma. Conclusion USC in Japanese women has characteristics different from those of endometrioid carcinoma, worse prognosis, and is difficult to diagnose preoperatively. Complete surgical staging is necessary even for early-stage disease. Additionally, new adjuvant treatment strategies, including molecular targeted therapy, should be explored.

This study aimed to determine whether the distance between the medial epicondyles of the femur is useful as a screening test for varus knee. The participants were 53 community-dwelling older adults. First, a receiver operating characteristic (ROC) curve analysis was performed to obtain the cutoff value for the distance between the medial epicondyles of the femur. The cutoff values and femorotibial angle (FTA) were used to compare body composition and physical function between the groups. The cutoff value for the distance between the medial epicondyles of the femur was 2.75 cm. The intergroup comparison based on the FTA revealed significant differences in lower-limb muscle mass, grip strength, and quadriceps muscle strength. The results of the cutoff value-based comparison showed significant differences in skeletal and lower-limb muscle mass, grip strength, and quadriceps muscle strength, all of which were consistent with each other. Measuring the distance between the medial epicondyles of the femur is a useful screening test for varus knees in community-dwelling older adults.

To determine the influence of “thin”, “normal”, and “obesity” on the motor function and exercise capacity of chronic obstructive pulmonary disease (COPD) patients, as well as whether “obesity” is actually “harmful” for such patients. A total of 103 COPD patients in a stable condition were classified into three groups: a “thin group” (BMI<18.5), an “normal group” (18.5≤BMI<25), and an “obesity group” (BMI≥25). Fourteen patients from each group matched for %FEV_1.0, sex, and age were evaluated. The measurement items were: respiratory function, respiratory muscle strength, lower and upper limb muscle strength, the 30-sec chair-stand test (CS-30), timed up and go test (TUG), 6-minute walking test (6MWT), incremental shuttle walking test (ISWT), Nagasaki university respiratory questionnaire (NRADL), and St. George’s respiratory questionnaire (SGRQ). As a result of comparing the three groups, the %MIP was significantly higher in the obesity compared to thin group (p=0.04). No differences were seen between the groups in the mMRC, %MEP, quadriceps femoris muscle strength (%), CS-30, TUG, 6MWT, ISWT, NRSDL, and SGRQ, but these values showed a tendency to be favorable in the obesity group. The BMI was significantly and positively correlated with the %MIP and NRADL. It was suggested that management of the respiratory muscle strength, exercise tolerance, and ADL when COPD patients are obese rather than thin can be possibly associated with a higher QOL.

As regards obesity screening tests, it's a widly known fact that there are many problems in the existing notation of various body indices.
Moreover, in regards to the determination of skin-fold thickness, measurments must be taken at two or three places, and this, plus the fact that a certain amount of expertise is necessary, represent a shortcoming.
Using abdominal girth, which can be relatively easily measured, together with the chest girth measurment, the author examined a method for assessing obesity.
Various body indices were computed from height, weight, chest measurement, abdominal girth, etc. and the correlation between their value and skin fold thickness and average skin fold thickness was determined.
As a result of this, abdominal girth measurement and evaluation may be used in obesity screen tests in the following way.
1. Method for measuring abdominal girth.
[1] Have the patient assume normal posture.
[2] Girth is measured (in centimeters) around the area mid way above the navel while the patient resting expiratory state with arms hanging limp and shoulders relaxed.
2. Method for computing obesity index.
obesity index=height (in cm) ×10/abdominal girth (in cm)
The subject of the above research is extreamly limited in respect to age range. Therefore, the authors would like to examine further to see if this method is applicable to all age renges.